Summary
- Current Price
- As of today, NBY price is $1.45, up +19.83% on
- Current Price All-Time High
- NBY price is currently -100.00% below its historical high of $650,781.25 set on
- Market Cap
- NBY current market cap is $183M, up +4815.10% over the past 365 days
- PE Ratio
- NBY PE ratio is unknown
- Revenue
- NBY current annual revenue is $9.78M, down -6.45% year-over-year
- Next Earnings
- As of today, the next earnings release for NBY has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | NovaBay Pharmaceuticals, Inc. |
| Ticker | NYSEAmerican: NBY |
| Exchange | NYSE American |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | novabay.com |
| Employees | 13 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $1.45 | |
| Price, 1D Change | +19.83% | |
| $183M | ||
| 275.86% | ||
| - | ||
| 1.34 | ||
| $10M | ||
| Revenue, 1Y Change | -6.45% | |
| -$12.65 | ||
| EPS, 1Y Change | +97.70% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $4.00 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:5 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$12.65 | ||
| EPS Estimate | N/A | - |
| EPS Est. Change | N/A | - |
| $9.78M | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| Current Price | $1.45 | |
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.31 | -$550.08 | -23,712.81% | |
| -$3.26 | -$12.65 | -288.18% | |
| - | N/A | - |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $14.40M | $10.46M | -27.40% | |
| $9.90M | $9.78M | -1.20% | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $1.45 | |
| $9.72 | ||
| SMA 200 vs Price | +570.57% | |
| $17.50 | ||
| SMA 50 vs Price | +1,106.84% | |
| 1.34 | ||
| $1.49 | ||
| 35.15 | ||
| 128.13% | ||
| 244.70% |
Dividends
| Metric | Date | Value |
|---|---|---|
| Last Paid | $4.00 | |
| Upcoming | N/A | N/A |
| - | ||
| Total Dividend | - | |
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $9.78M | ||
| -$12.65 | ||
| $6.48M | ||
| 66.26% | ||
| -$4.97M | ||
| -50.85% | ||
| -$7.21M | ||
| -73.71% | ||
| -$4.59M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| -12.96 | ||
| 0.68 | ||
| 0.41 | ||
| - | ||
| - | ||
| -3.47 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 64.65 | ||
| -68.19 | ||
| -26.60 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| -$135.00K | ||
| $430.00K | ||
| $45.91M | ||
| $1.94M | ||
| $46.04M | ||
| $2.84M | ||
| $1.67M | ||
| $963.00K | ||
| $623.00K |
Expenses
| Metric | Date | Value |
|---|---|---|
| $16.99M | ||
| $11.46M | ||
| $3.30M | ||
| $11.41M | ||
| $381.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$5.18M | ||
| $1.06M | ||
| $1.50M | ||
| $6,000.00 | ||
| -$5.19M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Ascendiant Capital | → | |
| Ladenburg Thalmann | → | |
| Ascendiant Capital | ||
| Ladenburg Thalmann | ||
| H.C. Wainwright | → | |
| Roth Capital | → | |
| Roth Capital | ||
| Maxim Group | → | |
| Maxim Group | ||
| Ascendiant Capital |
Analyst sentiment
Institutional ownership
Screeners with NBY
FAQ
What is the ticker symbol for NovaBay Pharmaceuticals, Inc.?
The ticker symbol for NovaBay Pharmaceuticals, Inc. is NYSEAmerican:NBY
Does NovaBay Pharmaceuticals, Inc. pay dividends?
Yes, NovaBay Pharmaceuticals, Inc. pays dividends. The last payment was $4.00, with an ex-dividend date on September 29, 2025
What sector is NovaBay Pharmaceuticals, Inc. in?
NovaBay Pharmaceuticals, Inc. is in the Healthcare sector
What industry is NovaBay Pharmaceuticals, Inc. in?
NovaBay Pharmaceuticals, Inc. is in the Biotechnology industry
What country is NovaBay Pharmaceuticals, Inc. based in?
NovaBay Pharmaceuticals, Inc. is headquartered in United States
When did NovaBay Pharmaceuticals, Inc. go public?
NovaBay Pharmaceuticals, Inc. initial public offering (IPO) was on October 26, 2007
Is NovaBay Pharmaceuticals, Inc. in the S&P 500?
No, NovaBay Pharmaceuticals, Inc. is not included in the S&P 500 index
Is NovaBay Pharmaceuticals, Inc. in the NASDAQ 100?
No, NovaBay Pharmaceuticals, Inc. is not included in the NASDAQ 100 index
Is NovaBay Pharmaceuticals, Inc. in the Dow Jones?
No, NovaBay Pharmaceuticals, Inc. is not included in the Dow Jones index
When was NovaBay Pharmaceuticals, Inc. last earnings report?
NovaBay Pharmaceuticals, Inc.'s most recent earnings report was on August 12, 2025
When does NovaBay Pharmaceuticals, Inc. report earnings?
The date for NovaBay Pharmaceuticals, Inc.'s next earnings report has not been announced yet
Data Sources & References
- NBY Official Website novabay.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1389545/000143774925010730/0001437749-25-010730-index.htm
- NBY Profile on Yahoo Finance finance.yahoo.com/quote/NBY
- NBY Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nby